Treace Medical ConceptsvsThermo Fisher Scientific

TMCI and TMO stock compared: price, dividend, valuation and results, from SEC filings.

TMCI

Treace Medical Concepts, Inc.

$4.42

Value $285M

-16.13%
TMCI's page

TMO

Thermo Fisher Scientific Inc

$691.33

Value $257B

-1.27%
TMO's page

Treace Medical Concepts (TMCI) has a market value of $285M and Thermo Fisher Scientific (TMO) $257B. Over the last year, with dividends, TMCI moved +45.9% and TMO +19.9%. Dividend yield: TMCI none, TMO 0.27%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    TMCI$285M

    TMO$257B

    TMO is 900 times TMCI

  • Revenue, 12 months

    TMCI$203M

    TMO$47.4B

    TMO is 233 times TMCI

  • Net income, 12 months

    TMCI-$56M

    TMO$7.1B

  • Operating margin

    TMCI-24.4%

    TMO17.9%

    42.3 points apart

  • ROIC

    TMCI-29.1%

    TMO8.2%

    37.3 points apart

  • P/E

    TMCI–

    TMO36.3

  • Dividend yield

    TMCI0.0%

    TMO0.3%

    0.3 points apart

  • 5-year return

    TMCI-78.5%

    TMO+10.9%

    89.4 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

TMCI-78.5%

TMO+10.9%

05010020222023202420252026
Returns by period
PeriodTMCIWith dividendsTMOWith dividends
1 year since November 14, 2025+45.9%Price +45.9%+19.9%Price +19.5%
3 years since November 16, 2023-47.1%-19.1% a yearPrice -47.1%+47.7%+13.9% a yearPrice +46.3%
5 years since November 15, 2021-78.5%-26.5% a yearPrice -78.5%+10.9%+2.1% a yearPrice +9.3%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

TMCITreace Medical ConceptsTMOThermo Fisher Scientific

Valuation

TMCITMO
Valuation
Price$4.42$691.33
Market value$285M$257B
Enterprise value (EV)–$292B
P/E–36.3
P/E, 5-year median–32.7
P/B4.64.7
EV/EBIT–34.5
Free cash flow yield–3.0%

Results and growth

TMCITMO
Results and growth
Revenue, 12 months$203M$47.4B
Net income, 12 months-$56M$7.1B
Free cash flow, 12 months-$19M$7.6B
Earnings per share, 12 months-$0.85$18.96
Revenue growth, year on year1.6%3.9%
Revenue growth a year, past+30.0%over 5 years+6.7%over 5 years
EPS growth a year, past–+2.1%over 5 years

Margins and returns on capital

TMCITMO
Margins and returns on capital
Gross margin79.6%–
Operating margin-24.4%17.9%
Net margin-27.4%14.9%
ROIC-29.1%8.2%
ROE-72.8%13.4%

Balance sheet

TMCITMO
Balance sheet
Cash$40M$6.1B
Total debt–$41.4B
Net debt / EBITDA–3.7
Interest cover-8.2×5.5×

Dividends and buybacks

TMCITMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield–1.2%
Shareholder yield–1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: TMCI or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, Treace Medical Concepts or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($257B) is about 899.6 times Treace Medical Concepts ($285M), at today's prices.

How did TMCI and TMO stock do over the last 5 years?

Since November 15, 2021, TMCI's price moved -78.5% and TMO's +9.3%. With dividends: TMCI -78.5% (-26.5% a year), TMO +10.9% (+2.1% a year). Past returns do not predict future ones.

Which pays the higher dividend, TMCI or TMO?

The dividend yield at today's price is none for Treace Medical Concepts and 0.27% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

Which has the higher profit margins, Treace Medical Concepts or Thermo Fisher Scientific?

Over the last twelve months, the net margin was -27.4% for Treace Medical Concepts and 14.9% for Thermo Fisher Scientific, and the operating margin -24.4% and 17.9%. Revenue was $203M and $47.4B.

Which is the better investment, Treace Medical Concepts or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.